Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Host gene that makes people vulnerable to leprosy discovered

10.02.2003


An international research team, led by Dr. Erwin Schurr and Dr. Thomas Hudson, Scientists at the Research Institute of the McGill University Health Centre, have identified a gene on human chromosome 6 that makes people vulnerable to leprosy. The study will be published in the March 2003 issue of Nature Genetics.



"This discovery will now allow us to study how the gene works and how it influences the infectious process. This is an important step toward the development of innovative prevention and treatment strategies for leprosy", stated Dr. Schurr.

"Leprosy has plagued humans for many centuries and it continues to be a concern in many countries," stated Dr. Marcel Behr, Infectious Disease Specialist at the MUHC and Assistant Professor of Medicine at McGill University. "These studies lead the way to developing better treatment and a possible vaccine."


Leprosy, a chronic disease caused by infection with the bacteria Mycobacterium leprae, affects approximately one million people worldwide. While it is a rare disease in Canada and the United States, the World Health Organization has identified 91 countries in which leprosy infection is highly prevalent. Symptoms of leprosy include pigmented skin lesions, permanent nerve damage leading to numbness of the feet and hands and, if left untreated, the disease may result in gross disfiguration including loss of finger, toes, feet and hands. The leprosy bacteria are transmitted through direct personal contact or contaminated respiratory droplets.

Schurr and his colleagues used a technique called "genome scanning" to map the gene. The research team analyzed DNA samples from nearly 100 families who were susceptible to the disease, and found that the families shared a common gene variant on chromosome 6. They then analyzed the DNA of an additional 200 families with leprosy to confirm their findings. "In the last few years advances in technology have made complex genetic analyses, such as those used in this study, possible, "stated Dr. Thomas Hudson. "Without these advances and the cooperation of the families, this research would not have been possible."

This is the second study, published in 2003 by McGill/CGDN scientists, that illustrates the importance of host genes in infectious disease. Dr. Philippe Gros discovered a gene (Naip-5) could make mice resistant to Legionnaire’s Disease. "We are now looking forward to applying the same gene identification strategies for other common infectious diseases such as tuberculosis and malaria", stated Dr. Alexandre Alcaïs, a scientist at the Institut National de la Santé et de la Recherche Médical (INSERM) Unité 550 at Necker Medical School, Paris, and co-author of the study.

Dr. Erwin Schurr is a Scientist at the McGill Centre for the Study of Host Resistance, a Researcher at the McGill University Health Centre, and an Investigator of the Canadian Genetic Diseases Network. Dr. Thomas Hudson is Director of the Genome Quebec Innovation Centre, a Scientist at the McGill University Health Centre, and an Investigator of the Canadian Genetic Diseases Network. The research was supported with grants from the Canadian Genetic Diseases Network, Canadian Institutes of Health Research, and Genome Quebec.

The Canadian Genetic Diseases Network is a not-for-profit corporation, committed to advancing Canada’s scientific and commercial competitiveness in genetic research, and the application of genetic discoveries to prevent, diagnose, and treat human disease. To achieve its objectives, CGDN participates in three essential activities: facilitates and funds collaborative research in human genetics across Canada; educates emerging scientists to excel in human genetic disease research; and facilitates partnerships between industry and academia to translate research discoveries into innovative therapies or diagnostic tests. CGDN is part of the Canadian Network Centres of Excellence program.

For Information contact:
Canadian Genetic Diseases Network:
Dean Sas, Corporate Development and Communications Manager
TEL: 604-221-7300 ext. 110
dsas@cgdn.ca

MUHC Communications Services:
Christine Zeindler
Communications Coordinator (Research)
514-934-1934 ext. 36419
pager: 514-406-1577


Christine Zeindler | EurekAlert!
Further information:
http://www.mcgill.ca/

More articles from Health and Medicine:

nachricht Chances to treat childhood dementia
24.07.2017 | Julius-Maximilians-Universität Würzburg

nachricht World first: Massive thrombosis removed during early pregnancy
20.07.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

Ultrathin device harvests electricity from human motion

24.07.2017 | Power and Electrical Engineering

Scientists announce the quest for high-index materials

24.07.2017 | Materials Sciences

ADIR Project: Lasers Recover Valuable Materials

24.07.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>